The Medipattern Corporation (CDNX:MKI.V - News), an award-winning developer of computer-aided detection (CAD) medical imaging software designed to detect cancer and permit a higher standard of care for the millions of patients at risk of cancer, is pleased to announce seven new B-CAD products: six versions of B-CAD for breast ultrasound imaging and one version for breast MRI (magnetic resonance imaging). Medipattern is the first and only company to cross the modality boundary, creating CAD products for breast ultrasound imaging and breast MRI from the same algorithm platform technology. The Company’s B-CAD solutions have been found to save time, increase consistency in reading, and document information in greater detail, providing a better record for tracking patients.
